| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/03/2013 | CN103189363A Bisaryl-bonded aryltriazolones and use thereof |
| 07/03/2013 | CN103189362A Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid |
| 07/03/2013 | CN103189353A Hydroxamate-based inhibitors of deacetylases |
| 07/03/2013 | CN103189060A Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound |
| 07/03/2013 | CN103184207A Agkistrodon acutus streptokinase and preparation method and application thereof |
| 07/03/2013 | CN103184170A Novel Lactobacillus LY-73 and its application |
| 07/03/2013 | CN103184135A Desert cistanche nutrition and health care vinegar |
| 07/03/2013 | CN103183726A Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides |
| 07/03/2013 | CN103183676A A group of 1-substituted-1, 8-naphthyridine formamide derivatives and preparation and application thereof |
| 07/03/2013 | CN103183660A Chromane derivative used as TRPV3 (transient receptor potential vanilloid 3) conditioning agent |
| 07/03/2013 | CN103183659A Chromane derivative used as TRPV3 (transient receptor potential vanillin 3) regulator |
| 07/03/2013 | CN103183630A Substituted 4-aminocyclohexane derivatives |
| 07/03/2013 | CN103183623A A group of benzene sulfonamido benzamide derivatives, and preparation and application thereof |
| 07/03/2013 | CN103183615A Extraction method of honeysuckle chlorogenic acid and its product |
| 07/03/2013 | CN103182090A Dna疫苗 Dna Vaccine |
| 07/03/2013 | CN103182049A Preparation method of pharmaceutical composition preparation treating apoplexy sequelae |
| 07/03/2013 | CN103182046A Traditional Chinese medicine granule for treating pulmonary heart disease, and preparation method thereof |
| 07/03/2013 | CN103182035A Traditional Chinese medicine composition used for treating chronic arrhythmia of elderly people and preparation method of traditional Chinese medicine composition |
| 07/03/2013 | CN103182033A Traditional Chinese medicinal composite effective ingredient preparation for treating ischemic stroke and preparation method thereof |
| 07/03/2013 | CN103182032A Gynostemma pentaphyllum pressure reduction preparation |
| 07/03/2013 | CN103182031A Health care Chinese medicinal composition |
| 07/03/2013 | CN103182029A Geriatric healthcare pill |
| 07/03/2013 | CN103182027A Healthcare medicine preparation method |
| 07/03/2013 | CN103182025A Traditional Chinese medicine composition for treating bradyarrhythmia, and application thereof |
| 07/03/2013 | CN103182021A Traditional Chinese medicine composition containing rehmannia root |
| 07/03/2013 | CN103182014A Hypotensive soluble granules |
| 07/03/2013 | CN103182012A Medicine for treating ischemic cerebral apoplexy and preparation method thereof |
| 07/03/2013 | CN103182011A Millipede ulcer and sore plaster |
| 07/03/2013 | CN103182009A Hypolipidemic traditional Chinese medicine composition and preparation method and application thereof |
| 07/03/2013 | CN103182008A Preparation method for traditional Chinese medicine used for stabilizing and reducing blood pressure |
| 07/03/2013 | CN103182007A Traditional Chinese medicine healthcare drug |
| 07/03/2013 | CN103182005A Agilawood fumigating method |
| 07/03/2013 | CN103182004A Composition for preventing or improving metabolic syndrome comprising tea llant leaf, flower and seed extract |
| 07/03/2013 | CN103181962A Traditional Chinese medicine effervescence particles for treating apoplexy sequela, and preparation method thereof |
| 07/03/2013 | CN103181936A Ginkgo flavone liposome oral emulsion formula and preparation method thereof |
| 07/03/2013 | CN103181935A Method for extracting medical total flavone from cupressus chengiana |
| 07/03/2013 | CN103181932A Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system |
| 07/03/2013 | CN103181922A Application of piperidone-containing single-carbonyl curcumin compound in preparation of anti-inflammatory drug |
| 07/03/2013 | CN103181909A Daphnetin slow-release composition and preparation method thereof |
| 07/03/2013 | CN103181893A Buffer solutionsha ving selective bactericidal activity against gramnegative bacteria and methods of using same |
| 07/03/2013 | CN103181885A Clopidogrel solid preparation and preparation method thereof |
| 07/03/2013 | CN103181884A Traditional Chinese medicine bath lotion |
| 07/03/2013 | CN103181565A PM2.5-preventing capsule for clearing away lung toxicant and protecting lungs |
| 07/03/2013 | CN102724986B Manufacturing method for dried earthworm powder |
| 07/03/2013 | CN102671103B Traditional Chinese medicine composition for treating endothelial cell dysfunction vascular diseases |
| 07/03/2013 | CN102670893B Traditional Chinese medicine composition for treating atherosclerosis |
| 07/03/2013 | CN102657646B Medicinal composition and preparation thereof |
| 07/03/2013 | CN102526276B Anti-hypertension medicinal composition and preparation method for same |
| 07/03/2013 | CN102416034B Medicament for treating myocardial ischemia in coronary heart disease and application thereof |
| 07/03/2013 | CN102379885B Pseudo-ginseng triol saponin enteric pellet and capsule and preparation method thereof |
| 07/03/2013 | CN102335414B Preparation method of rice prolamin bile acid adsorbent |
| 07/03/2013 | CN102319233B Application of pterostilbene in inhibiting vascular endothelial apoptosis |
| 07/03/2013 | CN102229601B Hexahydro-1-(5-isoquinoline sulfonyl)-1 (H)-1, 4- diazepine hydrochloride amorphous compound |
| 07/03/2013 | CN102199161B Benzene sulfonic acid clopidogrel with crystal form I, preparation method thereof and application thereof |
| 07/03/2013 | CN102188401B Felodipine sustained-release tablet and preparation method thereof |
| 07/03/2013 | CN102139023B Health-care tobacco-control type Chinese medicinal herb sucking product and preparation method |
| 07/03/2013 | CN102120746B Clopidogrel hydrochloride crystal form II as well as preparation method and application thereof |
| 07/03/2013 | CN102060845B Fasudil crystal formation III as well as preparation method and application thereof |
| 07/03/2013 | CN102048809B Medicine for treating coronary heart disease and preparation method thereof |
| 07/03/2013 | CN102028912B Externally applied traditional Chinese medicine powder for diminishing inflammation and swelling |
| 07/03/2013 | CN101987200B Compound medicine containing antihypertensive peptide and aldosterone receptor antagonist for curing hypertension |
| 07/03/2013 | CN101952259B Benzodiazepine compound and pharmaceutical composition |
| 07/03/2013 | CN101787061B Application of Quzhazhigan in preparation of preparations for preventing and treating cardiac-cerebral ischemia diseases, and preparation method thereof |
| 07/03/2013 | CN101035530B VEGF inhibition |
| 07/02/2013 | US8476286 Quinazoline derivatives which promote the release of parathyroid hormone |
| 07/02/2013 | US8476282 Benzoxazole kinase inhibitors and methods of use |
| 07/02/2013 | US8476221 Methods and compositions for the treatment of metabolic disorders |
| 07/02/2013 | US8476220 Biocompatible polymers, process for their preparation and compositions containing them |
| 07/02/2013 | US8475840 Sustained release formulation for oral administration of HMG-CoA reductase inhibitor and method for the preparation thereof |
| 07/02/2013 | US8475839 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
| 07/02/2013 | CA2742946C Antioxidant |
| 07/02/2013 | CA2504582C Drug delivery device comprising a bilayered polymeric coating having an inhibitor of the mamalian target of rapamycin incorporated into the first polymeric coating layer |
| 07/02/2013 | CA2445729C Use of metals to treat mucosal membranes |
| 06/27/2013 | WO2013095307A1 New crystal salts of zofenopril, process for obtaining them and their use in therapy |
| 06/27/2013 | WO2013093870A1 microRNAs FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION |
| 06/27/2013 | WO2013093753A1 Ivabradine hydrochloride premix |
| 06/27/2013 | WO2013093484A1 Pyridinone and pyrimidinone derivatives as factor xia inhibitors |
| 06/27/2013 | WO2013093027A1 Use of c1-inhibitor for the treatment of secondary edema of the central nervous system |
| 06/27/2013 | WO2013092984A1 Combination of (3s,3s') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) and a second antihypertensive agent |
| 06/27/2013 | WO2013092791A1 Novel dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| 06/27/2013 | WO2013091574A1 Pharmaceutical composition comprising candesartan or ester thereof and chlortalidone, and use thereof |
| 06/27/2013 | WO2013090978A1 Dosage regime for apolipoprotein formulations |
| 06/27/2013 | US20130165503 Method for Treating Ocular Neovascularization |
| 06/27/2013 | US20130165461 Methods of treating heart failure |
| 06/27/2013 | US20130165380 Administration of an antagonist of a5ß1 for anti-angiogenesis and cancer treatment |
| 06/27/2013 | US20130164815 Process for the production of a reversibly inactive acidified plasmin composition |
| 06/27/2013 | US20130164341 Preparation of formulations of angiotensin ii at1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications |
| 06/27/2013 | US20130164273 Reversibly inactivated acidified plasmin composition |
| 06/27/2013 | CA2857968A1 Dosage regime for apolipoprotein formulations |
| 06/26/2013 | EP2607363A1 Fused ring compound for use as mineralocorticoid receptor antagonist |
| 06/26/2013 | EP2607358A1 Novel anti-inflammatory metabolite derived from omega-3-type fatty acid |
| 06/26/2013 | EP2607348A2 Plasminogen Activator Inhibitor-1 Inhibitor |
| 06/26/2013 | EP2606901A1 Neuregulin based methods and compositions for treating cardiovascular diseases |
| 06/26/2013 | EP2606045A1 Oxadiazole inhibitors of leukotriene production |
| 06/26/2013 | EP2605797A2 Therapeutic peptide-polymer conjugates, particles, compositions, and related methods |
| 06/26/2013 | EP2605789A2 Modified relaxin polypeptides and their uses |
| 06/26/2013 | EP2605658A1 Spiroxazolidinone compounds |
| 06/26/2013 | EP2349304B1 Uses of curculigo latifolia (c. latifolia) extracts |
| 06/26/2013 | CN103180444A Injectable pharmaceutical composition for preventing, stabilising and/or inhibiting pathological neovascularization-related conditions |
| 06/26/2013 | CN103180327A Ring-fused 4 -aminopyrimidines and use thereof as stimulators of soluable guanylate cyclases |